SEC | GenomeWeb

SEC

Insider Info

A clinical trial PI faces insider-trading charges, according to Pharmalot's Ed Silverman.

The company did not specify the number of shares it will offer or the offering price, but said it intends to trade on the Nasdaq Global Market.

The company previously said in an SEC document that it raised $16.1 million toward a targeted goal of $30 million.

NEW YORK (GenomeWeb) — Bio-Rad Laboratories has resolved a US Securities and Exchange Commission investigation into its violation of the Foreign Corrupt Practices Act due to the company's subsidiaries having made improper payments to foreign officials in Russia, Vietnam, and Thailand in order to

NEW YORK (GenomeWeb) – Molecular diagnostics firm AutoGenomics has refiled for an initial public offering, less than one year after it pulled earlier plans to go public.

NEW YORK (GenomeWeb) – Agilent Technologies said in a regulatory document on Monday that an investigation by US regulators into possible infractions by the company's employees in China has ended without any enforcement actions by the agencies.

NEW YORK (GenomeWeb News) – Agilent Technologies has launched an investigation into activities of certain of its employees in China for possible infractions of US law, the company said in its Form 10-Q.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Bruker said this week it has found that certain employees in its Bruker Optics subsidiary bribed officials in China and the company has fired them.

Quark Pharmaceuticals this week pulled its planned initial public offering on the Nasdaq, marking the second false start the company has had in attempting to float shares in the US.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.